Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83,125 | 78,595 | 93,328 | 60,247 | 74,229 |
| Marketable Securities | N/A | 0 | 0 | 0 | 6,989 |
| Receivables | 16,994 | 16,096 | 12,866 | 12,943 | 9,729 |
| Inventories | 17,877 | 18,752 | 16,131 | 14,507 | 14,486 |
| TOTAL | $121,790 | $116,948 | $126,170 | $91,674 | $112,197 |
| Non-Current Assets | |||||
| PPE Net | 10,729 | 10,843 | 11,139 | 10,425 | 10,174 |
| Intangibles | 35,674 | 36,385 | 37,387 | 37,758 | 38,310 |
| Other Non-Current Assets | 12,176 | 13,068 | 14,183 | 14,440 | 15,350 |
| TOTAL | $58,579 | $60,296 | $62,709 | $62,623 | $63,834 |
| Total Assets | $180,369 | $177,244 | $188,879 | $154,297 | $176,031 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,776 | 11,890 | 11,732 | 8,683 | 10,628 |
| Accrued Expenses | 13,433 | 13,194 | 14,728 | 14,300 | 16,519 |
| TOTAL | $35,345 | $35,523 | $37,390 | $33,223 | $37,055 |
| Non-Current Liabilities | |||||
| Long Term Debt | 75,254 | 63,818 | 63,636 | 63,455 | 63,277 |
| Deferred Revenues | 6,688 | 6,850 | 7,214 | 6,657 | 6,279 |
| Other Non-Current Liabilities | 12,003 | 12,147 | 12,304 | 12,324 | 14,242 |
| TOTAL | $91,254 | $79,748 | $79,588 | $78,950 | $80,395 |
| Total Liabilities | $126,599 | $115,271 | $116,978 | $112,173 | $117,450 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,141 | 49,076 | 48,941 | 38,406 | 38,342 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -230,071 | -219,269 | -206,353 | -185,550 | -166,748 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -6 |
| TOTAL | $53,770 | $61,973 | $71,901 | $42,124 | $58,581 |
| Total Liabilities And Equity | $180,369 | $177,244 | $188,879 | $154,297 | $176,031 |